NCT06823375 2026-03-04SBRT With Immunotherapy and Atezo-Bev in HCC With Major Portal Vein ThrombosisChinese University of Hong KongPhase 2 Recruiting40 enrolled
NCT06413017 2024-05-14Nimotuzumab Combined With ICIs for the Treatment of Advanced Liver Cancer After First Line Treatment FailureTianjin Medical University Cancer Institute and HospitalPhase 2 Recruiting30 enrolled